BURCAR ALISON D 4
4 · ICU MEDICAL INC/DE · Filed Jun 21, 2018
Insider Transaction Report
Form 4
BRUMMETT BURCAR ALISON
Vice President Marketing
Transactions
- Sale
Common Stock
2018-06-21$295.27/sh−3,320$980,296→ 11,875 total - Sale
Common Stock
2018-06-21$298.24/sh−1,412$421,115→ 257 total - Sale
Common Stock
2018-06-21$301.12/sh−257$77,388→ 0 total - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-06-21−1,976→ 0 totalExercise: $58.79Exp: 2024-02-24→ Common Stock (1,976 underlying) - Exercise of In-Money
Non-Qualified Stock Option (right to buy)
2018-06-21−13,219→ 0 totalExercise: $88.76Exp: 2025-02-11→ Common Stock (13,219 underlying) - Sale
Common Stock
2018-06-21$296.34/sh−4,704$1,393,983→ 7,171 total - Sale
Common Stock
2018-06-21$297.38/sh−5,502$1,636,185→ 1,669 total - Exercise of In-Money
Common Stock
2018-06-21$88.76/sh+13,219$1,173,318→ 13,219 total - Exercise of In-Money
Common Stock
2018-06-21$58.79/sh+1,976$116,169→ 15,195 total
Footnotes (8)
- [F1]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $294.75 to $295.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F2]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $295.80 to $296.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F3]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $296.85 to $297.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F4]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $297.95 to $298.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F5]The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- [F6]Options exercisable in four equal annual cumulative installments commencing one year after the grant date.
- [F7]Transaction is the exercise of a derivative security; see Column 2.
- [F8]Options exercisable one-third annually over the first three anniversaries of the grant date.